Synapse - Miguel-Angel Perales

Results (942)

Clinical outcomes of acute myeloid leukemia patients bridged to allogeneic stem cell transplant by venetoclax combination therapy

Meeting Abstract

Stahl, M.; Menghrajani, K.; Derkach, A.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; Barker, J.; more...
Blood (2020)

Fulltext@MSK | Save

Bridging the gap in access to transplant for underserved minority patients using mismatched unrelated donors and post-transplant cyclophosphamide: A National Marrow Donor Program/Be The Match (NMDP/BTM) Initiative

Meeting Abstract

Shaw, B. E.; Jimenez-Jimenez, A.; Burns, L. J.; Logan, B.; Khimani, F.; Shaffer, B. C.; Shah, N. N.; Mussetter, A.; Tang, X. Y.; McCarty, J. M.; more...
Blood (2020)

Fulltext@MSK | Save

Molecular predictors and effectiveness of measurable residual disease (MRD) eradication with chemotherapy and allogeneic stem cell transplantation for acute myeloid leukemia

Meeting Abstract

Stahl, M.; Derkach, A.; Famulare, C.; Cho, C.; Devlin, S.; Farnoud, N.; Menghrajani, K.; Patel, M. A.; Cai, S. F.; Geyer, M. B.; more...
Blood (2020)

Fulltext@MSK | Save

Secondary graft-versus-host disease (GVHD) prophylaxis with oral proteasome inhibitor ixazomib is associated with low incidence of recurrent, late acute and chronic GVHD and facilitated calcineurin inhibitor taper within the first year post allogeneic stem cell transplantation

Meeting Abstract

Rodriguez, N.; Lee, J.; Flynn, L.; Murray, F.; Devlin, S.; Izquierdo, C. S.; Cho, C.; Dahi, P. B.; Giralt, S. A.; Sauter, C. S.; more...
Blood (2020)

Fulltext@MSK | Save

Rabbit anti-thymocyte globulin exposure (rATG) in CD34+ selected hematopoietic cell transplantation and its impact on immune reconstitution and outcomes in children and adults

Meeting Abstract

Lakkaraja, M.; Scordo, M.; Mauguen, A.; Cho, C.; Devlin, S.; Avecilla, S. T.; Boulad, F.; Cancio, M. I.; Curran, K. J.; Jakubowski, A. A.; more...
Blood (2020)

Fulltext@MSK | Save

Outcomes of patients (pts) in ZUMA-9, a multicenter, open-label study of axicabtagene ciloleucel (axi-cel) in relapsed/refractory large B cell lymphoma (R/R LBCL) for expanded access and commercial out-of-specification (OOS) product

Meeting Abstract

Jacobson, C. A.; Locke, F. L.; Miklos, D. B.; Vose, J. M.; Lin, Y.; Budde, L. E.; Maloney, D. G.; Jaglowski, S.; Riedell, P. A.; Lekakis, L. J.; more...
Blood (2020)

Fulltext@MSK | Save

Clinical impact of bridging therapy prior to commercial chimeric antigen receptor (CAR) T-cell therapies for relapsed/refractory lymphomas

Meeting Abstract

Imber, B. S.; Perales, M. A.; Flynn, J.; Ruiz, J. D.; Devlin, S.; Alarcon Tomas, A.; Hajj, C.; Batlevi, C. L.; Dahi, P. B.; Lin, R. J.; more...
Blood (2020)

Fulltext@MSK | Save

TCR repertoires in graft-versus-host-disease (GVHD)-target tissues reveals tissue specificity of the alloimmune response

Meeting Abstract

DeWolf, S.; Nichols, K.; Nguyen, C. L.; Giardina, P. A.; Slingerland, J. B.; Elias, H.; Kappangantula, R.; Baez, P.; Murali, R.; Hayashi, A.; more...
Blood (2020)

Fulltext@MSK | Save

A single-arm, open-label phase 1 study of itacitinib (ITA) with calcineurin inhibitor (CNI)-based interventions for prophylaxis of graft-versus-host disease (GVHD; GRAVITAS-119)

Meeting Abstract

Choe, H.; Shah, N. N.; Chevallier, P.; Rubio, M. T.; Schroeder, M. A.; Hardy, N. M.; Stiff, P. J.; Solano, C.; Yakoub-Agha, I.; Gutman, J. A.; more...
Blood (2020)

Fulltext@MSK | Save

Preliminary results of the first-in-human study of NEXI-001, a multi-antigen specific CD8+ T cell product, in acute myeloid leukemia (AML) patients with relapsed disease after allogeneic hematopoietic cell transplantation (allo-HSCT) demonstrate early signs of safety, tolerability and robust immune responses

Meeting Abstract

Al Malki, M. M.; Perales, M. A.; Modi, M. D.; Vasu, S.; Nelson, M.; Bui, D.; Kim, S.; Wang, R. P.; Lu, E.; Oelke, M.; more...
Blood (2020)

Fulltext@MSK | Save